PE20110573A1 - Sistema de administracion de drogas que contiene progestina - Google Patents
Sistema de administracion de drogas que contiene progestinaInfo
- Publication number
- PE20110573A1 PE20110573A1 PE2011000137A PE2011000137A PE20110573A1 PE 20110573 A1 PE20110573 A1 PE 20110573A1 PE 2011000137 A PE2011000137 A PE 2011000137A PE 2011000137 A PE2011000137 A PE 2011000137A PE 20110573 A1 PE20110573 A1 PE 20110573A1
- Authority
- PE
- Peru
- Prior art keywords
- progestin
- film matrix
- drug administration
- administration system
- containing drug
- Prior art date
Links
- 238000001647 drug administration Methods 0.000 title 1
- 239000011159 matrix material Substances 0.000 abstract 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 2
- 239000010408 film Substances 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 239000000583 progesterone congener Substances 0.000 abstract 2
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 abstract 1
- RWBRUCCWZPSBFC-RXRZZTMXSA-N (20S)-20-hydroxypregn-4-en-3-one Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](O)C)[C@@]1(C)CC2 RWBRUCCWZPSBFC-RXRZZTMXSA-N 0.000 abstract 1
- ATXHVCQZZJYMCF-XUDSTZEESA-N Allylestrenol Chemical compound C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)CC=C)[C@@H]4[C@@H]3CCC2=C1 ATXHVCQZZJYMCF-XUDSTZEESA-N 0.000 abstract 1
- 235000010919 Copernicia prunifera Nutrition 0.000 abstract 1
- 244000180278 Copernicia prunifera Species 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- -1 NORETINDRONE Chemical compound 0.000 abstract 1
- XLYOFNOQVPJJNP-PWCQTSIFSA-N Tritiated water Chemical compound [3H]O[3H] XLYOFNOQVPJJNP-PWCQTSIFSA-N 0.000 abstract 1
- 229960002692 allylestrenol Drugs 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 229960004400 levonorgestrel Drugs 0.000 abstract 1
- HCFSGRMEEXUOSS-JXEXPEPMSA-N medrogestone Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(C)[C@@]1(C)CC2 HCFSGRMEEXUOSS-JXEXPEPMSA-N 0.000 abstract 1
- 229960000606 medrogestone Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 229920000193 polymethacrylate Polymers 0.000 abstract 1
- 239000003223 protective agent Substances 0.000 abstract 1
- 239000007962 solid dispersion Substances 0.000 abstract 1
- 239000010409 thin film Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Botany (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pregnancy & Childbirth (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
REFERIDA A UNA FORMA DE DOSIFICACION INDIVIDUAL QUE COMPRENDE UNA MATRIZ DE PELICULA DELGADA SOLUBLE EN AGUA, DONDE: A) DICHA MATRIZ DE PELICULA COMPRENDE AL MENOS UN POLIMERO DE MATRIZ EN AGUA; B) DICHA MATRIZ DE PELICULA COMPRENDE PARTICULAS, DONDE DICHAS PARTICULAS COMPRENDEN AL MENOS UNA PROGESTINA PRESENTE EN UNA DISPERSION SOLIDA Y AL MENOS UN AGENTE PROTECTOR SELECCIONADO DE POLIMETACRILATO CATIONICO, CARNAUBA, ENTRE OTROS Y C) DICHA MATRIZ DE PELICULA TIENE UN GROSOR < 300 um. LA PROGESTINA SE SELECCIONA DEL GRUPO QUE COMPRENDE LEVONORGESTREL, NORETINDRONA, DIHIDROGESTERONA, ALILESTRENOL, MEDROGESTONA, PROMEGESTRONA, ENTRE OTROS. DICHA COMPOSICION ES UTIL EN LA ANTICONCEPCION EN UN MAMIFERO HEMBRA
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8733408P | 2008-08-08 | 2008-08-08 | |
| EP08162105 | 2008-08-08 | ||
| PCT/EP2009/000904 WO2009100871A2 (en) | 2008-02-13 | 2009-02-10 | Drug delivery system with stabilising effect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20110573A1 true PE20110573A1 (es) | 2011-08-12 |
Family
ID=40210465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2011000137A PE20110573A1 (es) | 2008-08-08 | 2009-08-07 | Sistema de administracion de drogas que contiene progestina |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20110293720A1 (es) |
| EP (1) | EP2331067A1 (es) |
| JP (1) | JP2011530499A (es) |
| KR (1) | KR20110044752A (es) |
| CN (1) | CN102119021A (es) |
| AR (1) | AR072933A1 (es) |
| AU (1) | AU2009279053A1 (es) |
| BR (1) | BRPI0917030A2 (es) |
| CA (1) | CA2732211A1 (es) |
| CO (1) | CO6351709A2 (es) |
| CR (1) | CR20110072A (es) |
| DO (1) | DOP2011000049A (es) |
| EA (1) | EA201100304A1 (es) |
| EC (1) | ECSP11010815A (es) |
| IL (1) | IL210590A0 (es) |
| MA (1) | MA32538B1 (es) |
| MX (1) | MX2011001519A (es) |
| PE (1) | PE20110573A1 (es) |
| SV (1) | SV2011003835A (es) |
| TW (1) | TW201008569A (es) |
| UY (1) | UY32041A (es) |
| WO (1) | WO2010015713A1 (es) |
| ZA (1) | ZA201101737B (es) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010086989A1 (ja) | 2009-01-29 | 2010-08-05 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
| HUP0900698A2 (en) * | 2009-11-06 | 2011-06-28 | Richter Gedeon Nyrt | Pharmaceutical compositions of enhanced stability containing drospirenone and ethynyl estradiol and process for their preparation |
| JP5588688B2 (ja) * | 2010-01-28 | 2014-09-10 | 日東電工株式会社 | フィルム状製剤 |
| JP2011207847A (ja) * | 2010-03-30 | 2011-10-20 | Nitto Denko Corp | フィルム状製剤及びその製造方法 |
| JP5751868B2 (ja) | 2010-03-30 | 2015-07-22 | 日東電工株式会社 | フィルム状製剤及びその製造方法 |
| AR081670A1 (es) | 2010-06-29 | 2012-10-10 | Leon Farma Sa Lab | Composicion farmaceutica que comprende drospirenona y kit anticonceptivo |
| US11351122B1 (en) | 2010-07-28 | 2022-06-07 | Laboratorios Leon Farma Sa | Synthetic progestogens and pharmaceutical compositions comprising the same |
| US10849857B2 (en) | 2010-07-28 | 2020-12-01 | Laboratorios Leon Farma Sa | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
| US9603860B2 (en) | 2010-07-28 | 2017-03-28 | Laboratorios Leon Farma Sa | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
| HUE026985T2 (en) | 2011-09-09 | 2016-07-28 | Philip Morris Products Sa | Smoking article containing a carrier material |
| US9044734B2 (en) | 2011-09-23 | 2015-06-02 | Basf Se | Diesel oxidation catalyst with layered structure containing ceria composition as palladium support material for enhanced HC and CO gas conversion |
| EP3936133A1 (en) | 2011-11-23 | 2022-01-12 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| JP5841433B2 (ja) | 2012-01-11 | 2016-01-13 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
| JP5952646B2 (ja) * | 2012-06-07 | 2016-07-13 | 救急薬品工業株式会社 | 口腔内溶解型フィルム製剤 |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10668156B2 (en) | 2012-06-22 | 2020-06-02 | Basf Se | Active-ingredient-containing solid dispersions based on diethylaminoethyl methacrylate copolymers |
| WO2013189776A1 (de) * | 2012-06-22 | 2013-12-27 | Basf Se | Wirkstoffhaltige festen dispersionen auf basis von diethylaminoethylmethacrylat-copolymeren |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| CN103040725B (zh) * | 2012-12-26 | 2015-01-21 | 武汉九珑人福药业有限责任公司 | 一种利用研磨改善屈螺酮溶出的方法及屈螺酮固体分散体 |
| JP6084468B2 (ja) * | 2013-01-24 | 2017-02-22 | アリメント工業株式会社 | シビレ緩和持続性唾液分泌促進剤、その製造方法、及びシビレ緩和持続性唾液分泌促進食品 |
| KR101407922B1 (ko) * | 2013-11-14 | 2014-06-17 | 주식회사 서울제약 | 약리학적 활성 성분을 포함하는 다공성 구강붕해필름 및 이의 제조방법 |
| US10206932B2 (en) | 2014-05-22 | 2019-02-19 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| KR20170040209A (ko) | 2014-07-29 | 2017-04-12 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 경피 크림 |
| US20160243036A1 (en) * | 2015-02-25 | 2016-08-25 | Intelgenx Corp. | Film dosage forms containing amorphous active agents |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| CA3020153A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| CN108606963B (zh) * | 2017-12-27 | 2021-05-18 | 上海长海医院 | 含有屈螺酮和雌激素的复方避孕贴、制备方法及应用 |
| CN108186586B (zh) * | 2018-03-01 | 2020-12-29 | 常州市第四制药厂有限公司 | 一种烯丙雌醇片剂及其制备方法 |
| CN108853017B (zh) * | 2018-09-17 | 2021-03-02 | 西安力邦医药科技有限责任公司 | 一种雌三醇纳米口服制剂的组方与制备工艺 |
| EP3954364A1 (en) * | 2020-08-14 | 2022-02-16 | Chemo Research, S.L. | New modified release oral contraceptive composition |
| AU2021351921A1 (en) | 2020-09-29 | 2023-04-06 | Millicent Pharma Limited | Orodispersible formulations |
| CN114767871B (zh) * | 2022-04-19 | 2023-04-07 | 中国工程物理研究院机械制造工艺研究所 | 介孔硅载药体系及制备方法和介孔硅载药 |
| CN119925640A (zh) * | 2025-02-13 | 2025-05-06 | 国家卫生健康委科学技术研究所 | 一种控释药物组合物的制备方法及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2769854B1 (fr) * | 1997-10-21 | 2000-03-31 | Prographarm Lab | Nouveau procede d'obtention de microspheres et les produits ainsi realises |
| MXPA05011343A (es) * | 2003-05-08 | 2005-12-12 | Nektar Therapeutics Uk Ltd | Materiales particulados. |
| US20050220825A1 (en) * | 2004-03-10 | 2005-10-06 | Adrian Funke | Molecular dispersions of drospirenone |
| US20080096979A1 (en) * | 2004-11-08 | 2008-04-24 | Rubicon Research Pvt. Ltd. | Aqueous Pharmaceutical Coating |
| DE102005015128B4 (de) * | 2005-03-31 | 2008-12-11 | Bayer Schering Pharma Aktiengesellschaft | Wafer enthaltend Steroidhormone |
| US20070077309A1 (en) * | 2005-09-30 | 2007-04-05 | Wong Patrick S | Banded controlled release nanoparticle active agent formulation dosage forms and methods |
| DE102006003512A1 (de) * | 2006-01-24 | 2007-08-02 | Bayer Schering Pharma Ag | Plättchenförmige Arzneimittel zur transbukkalen Applikation von Arzneistoffen |
-
2009
- 2009-08-06 TW TW098126657A patent/TW201008569A/zh unknown
- 2009-08-07 CN CN2009801310695A patent/CN102119021A/zh active Pending
- 2009-08-07 EP EP09781632A patent/EP2331067A1/en not_active Withdrawn
- 2009-08-07 EA EA201100304A patent/EA201100304A1/ru unknown
- 2009-08-07 WO PCT/EP2009/060298 patent/WO2010015713A1/en not_active Ceased
- 2009-08-07 KR KR1020117002831A patent/KR20110044752A/ko not_active Withdrawn
- 2009-08-07 BR BRPI0917030A patent/BRPI0917030A2/pt not_active IP Right Cessation
- 2009-08-07 MX MX2011001519A patent/MX2011001519A/es not_active Application Discontinuation
- 2009-08-07 US US13/057,299 patent/US20110293720A1/en not_active Abandoned
- 2009-08-07 AU AU2009279053A patent/AU2009279053A1/en not_active Abandoned
- 2009-08-07 PE PE2011000137A patent/PE20110573A1/es not_active Application Discontinuation
- 2009-08-07 JP JP2011521597A patent/JP2011530499A/ja not_active Withdrawn
- 2009-08-07 CA CA2732211A patent/CA2732211A1/en not_active Abandoned
- 2009-08-10 UY UY0001032041A patent/UY32041A/es not_active Application Discontinuation
- 2009-08-10 AR ARP090103070A patent/AR072933A1/es not_active Application Discontinuation
-
2011
- 2011-01-12 IL IL210590A patent/IL210590A0/en unknown
- 2011-02-04 MA MA33583A patent/MA32538B1/fr unknown
- 2011-02-08 CO CO11014595A patent/CO6351709A2/es not_active Application Discontinuation
- 2011-02-08 CR CR20110072A patent/CR20110072A/es unknown
- 2011-02-08 SV SV2011003835A patent/SV2011003835A/es unknown
- 2011-02-08 EC EC2011010815A patent/ECSP11010815A/es unknown
- 2011-02-08 DO DO2011000049A patent/DOP2011000049A/es unknown
- 2011-03-07 ZA ZA2011/01737A patent/ZA201101737B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CR20110072A (es) | 2011-03-30 |
| KR20110044752A (ko) | 2011-04-29 |
| WO2010015713A1 (en) | 2010-02-11 |
| US20110293720A1 (en) | 2011-12-01 |
| MA32538B1 (fr) | 2011-08-01 |
| JP2011530499A (ja) | 2011-12-22 |
| EA201100304A1 (ru) | 2011-08-30 |
| CN102119021A (zh) | 2011-07-06 |
| ZA201101737B (en) | 2013-08-28 |
| EP2331067A1 (en) | 2011-06-15 |
| AU2009279053A1 (en) | 2010-02-11 |
| AR072933A1 (es) | 2010-09-29 |
| CO6351709A2 (es) | 2011-12-20 |
| CA2732211A1 (en) | 2010-02-11 |
| BRPI0917030A2 (pt) | 2017-03-21 |
| TW201008569A (en) | 2010-03-01 |
| IL210590A0 (en) | 2011-03-31 |
| DOP2011000049A (es) | 2011-03-15 |
| MX2011001519A (es) | 2011-03-29 |
| ECSP11010815A (es) | 2011-03-31 |
| UY32041A (es) | 2010-03-26 |
| SV2011003835A (es) | 2011-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20110573A1 (es) | Sistema de administracion de drogas que contiene progestina | |
| AR038575A1 (es) | Formulacion oftalmica con nueva composicion de goma | |
| AR072544A1 (es) | Metodo anticonceptivo mejorado. sistema de suministro. uso. progestageno | |
| JP2011518842A5 (es) | ||
| AR115939A2 (es) | Composición que contiene palmitoil-etanolamida ultra-micronizada | |
| AR073704A1 (es) | Sistema de administracion transdermal de droga para principios activos liquidos que tiene una capa de matriz adhesiva que incluye un ingrediente farmaceutico activo que es seleccionado entre selegilina y rivastigmina | |
| CL2007002485A1 (es) | Proceso para preparar una forma de dosificacion farmaceutica oral solida de leberacion extendida que comprende un agente aactivo y oxido de polietileno de peso molecular de al menos 1.000.000, que incluye un paso de curado sometiendola a la temperatura de reblandecimiento o fusion (al menos parcial) del oxido de polietileno. | |
| UA113549C2 (xx) | Біорозкладений засіб доставки лікарських засобів для гідрофобних композицій | |
| AR077199A1 (es) | Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia | |
| DOP2010000318A (es) | Formulaciones mejoradas para ingredientes farmaceuticos activos de permeabilidad deficiente | |
| PE20091574A1 (es) | Sistema de administracion de drogas con efecto estabilizante | |
| UY39192A (es) | Dispersión sólida, proceso para prepararla y forma de dosificación farmacéutica suministrable por vía oral que la comprende | |
| NZ610701A (en) | Once daily formulation of lacosamide | |
| MX2020005942A (es) | Delgada pelicula oral con alta carga de agente activo. | |
| AR070025A1 (es) | Uso de derivados de 1-amino-alquilciclohexano para el tratamiento del tinnitus coclear y composicion farmaceutica | |
| AR078020A1 (es) | Dispositivo de administracion pericorneal de farmacos | |
| MX2010005013A (es) | Composiciones intranasales. | |
| BR112017008993A2 (pt) | métodos e composições especificamente para o tratamento de transtorno de déficit de atenção | |
| AR083361A1 (es) | Forma de dosificacion de rapida disolucion de vacuna oral utilizando almidon | |
| CR20170142A (es) | Composiciones farmacéuticas resistentes al abuso | |
| CO6170417A2 (es) | Formulaciones orales liofilizadas de desintegracion rapida de un antagonista del receptor de trombina | |
| PE20151783A1 (es) | Dispersion solida de un modulador selectivo de los receptores de progesterona | |
| MX2019015927A (es) | Composiciones para administración de fármacos y métodos de uso de las mismas. | |
| BR112015022398A8 (pt) | comprimido de ondansetrona e preparação farmacêutica embalada | |
| AR070375A1 (es) | Sistemas de administracion de drogas que contienen estradiol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |